Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark. Issue 9 (9th June 2022)
- Record Type:
- Journal Article
- Title:
- Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark. Issue 9 (9th June 2022)
- Main Title:
- Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark
- Authors:
- Bollerup, Signe
Hallager, Sofie
Engsig, Frederik
Mocroft, Amanda
Krarup, Henrik
Madsen, Lone G.
Thielsen, Peter
Balslev, Ulla
Mens, Helene
Barfod, Toke S.
Clausen, Mette R.
Hobolth, Lise
Laursen, Alex L.
Tarp, Britta
Roege, Birgit T.
Hansen, Jesper B.
Mygind, Lone
Christensen, Peer B.
Gerstoft, Jan
Weis, Nina - Abstract:
- Abstract: The study aimed to determine adjusted all‐cause mortality and cause of death in persons with chronic hepatitis B virus (HBV) infection compared with age‐ and sex‐matched persons from the general population. We used nationwide registers to identify persons aged ≥18 years with chronic HBV infection in 2002–2017 in Denmark and included 10 age‐ and sex‐matched controls for each. Follow‐up was from 6 months after diagnosis until death, emigration, or 31 December 2017. Mortality rate ratios (MRRs) adjusted for age, sex, employment, origin and comorbidity were calculated using Poisson regression. Unadjusted cause‐specific mortality rate ratios with 95% confidence intervals were calculated assuming a Poisson distribution. A total of 6988 persons with chronic HBV infection and 69, 847 controls were included. During a median follow‐up of 7.7 years (range 0.0–15.5), 315 (5%) persons with—and 1525 (2%) without—chronic HBV infection died. The adjusted all‐cause MRR was 1.5 (95% CI 1.2–2.0). Persons with chronic HBV infection had increased mortality due to liver disease including hepatocellular carcinoma (MRR 12.3 [8.6–17.7]), external causes (MRR 3.3 [2.5–4.7]), endocrine disease (MRR 3.2 [1.8–5.4]), genitourinary disease (MRR 3.2 [1.2–7.6]) and neoplasms (except hepatocellular carcinoma; MRR 1.6 [1.2–2.0]). In conclusion, this study showed an increased all‐cause mortality in persons with chronic HBV infection in comparison with age‐ and sex‐matched persons without chronic HBVAbstract: The study aimed to determine adjusted all‐cause mortality and cause of death in persons with chronic hepatitis B virus (HBV) infection compared with age‐ and sex‐matched persons from the general population. We used nationwide registers to identify persons aged ≥18 years with chronic HBV infection in 2002–2017 in Denmark and included 10 age‐ and sex‐matched controls for each. Follow‐up was from 6 months after diagnosis until death, emigration, or 31 December 2017. Mortality rate ratios (MRRs) adjusted for age, sex, employment, origin and comorbidity were calculated using Poisson regression. Unadjusted cause‐specific mortality rate ratios with 95% confidence intervals were calculated assuming a Poisson distribution. A total of 6988 persons with chronic HBV infection and 69, 847 controls were included. During a median follow‐up of 7.7 years (range 0.0–15.5), 315 (5%) persons with—and 1525 (2%) without—chronic HBV infection died. The adjusted all‐cause MRR was 1.5 (95% CI 1.2–2.0). Persons with chronic HBV infection had increased mortality due to liver disease including hepatocellular carcinoma (MRR 12.3 [8.6–17.7]), external causes (MRR 3.3 [2.5–4.7]), endocrine disease (MRR 3.2 [1.8–5.4]), genitourinary disease (MRR 3.2 [1.2–7.6]) and neoplasms (except hepatocellular carcinoma; MRR 1.6 [1.2–2.0]). In conclusion, this study showed an increased all‐cause mortality in persons with chronic HBV infection in comparison with age‐ and sex‐matched persons without chronic HBV infection which remained after adjustment for several confounding factors. Excess mortality was mainly associated with liver disease, but also external factors, endocrine disease, genitourinary disease and neoplasms (excluding hepatocellular carcinoma). … (more)
- Is Part Of:
- Journal of viral hepatitis. Volume 29:Issue 9(2022)
- Journal:
- Journal of viral hepatitis
- Issue:
- Volume 29:Issue 9(2022)
- Issue Display:
- Volume 29, Issue 9 (2022)
- Year:
- 2022
- Volume:
- 29
- Issue:
- 9
- Issue Sort Value:
- 2022-0029-0009-0000
- Page Start:
- 727
- Page End:
- 736
- Publication Date:
- 2022-06-09
- Subjects:
- DANHEP -- general population -- hepatitis B -- nationwide -- Scandinavia
Hepatitis, Viral -- Periodicals
Hepatitis, Viral, Animal
Hepatitis, Viral, Human
616.3623 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2893 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=jvh ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1352-0504;screen=info;ECOIP ↗ - DOI:
- 10.1111/jvh.13713 ↗
- Languages:
- English
- ISSNs:
- 1352-0504
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5072.485500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23000.xml